Can-Fite BioPharma Ltd. (NYSE: CANF) (TASE: CFBI) announced financial results for the year ended December 31, 2021.
The company said that it had $18.9 million in cash, cash equivalents, and short-term deposits, on December 31, 2021.
Chimerix Inc's (NASDAQ: CMRX) preclinical data from its CMX521 program will be featured at the International Conference on Antiviral Research (ICAR) in March.